Exclusive

Singapore approves Merck's CAPVAXIVE 21-valent pneumococcal conjugate vaccine

Singapore, Oct. 29 -- American multinational pharmaceutical company Merck (Known as Merck Sharp & Dohme or MSD outside the United States and Canada) has announced that the Health Sciences Authority (H... Read More


M42, American University in Dubai partner to advance healthcare talent

Singapore, Oct. 29 -- M42 and the American University in Dubai (AUD) have signed a Memorandum of Understanding (MoU) to expand practical learning opportunities for biology and pre-medical students, st... Read More


"The Future of Brain-Computer Interfaces Will Be Measured by Independence, Not Laboratory Performance"

Singapore, Oct. 29 -- Brain-computer interfaces (BCIs) are entering a new phase of technological development, moving beyond experimental demonstrations towards practical applications that could transf... Read More


Gilead buys oral IL-23R inhibitor programme from China's PepStar for $1.27 B

Singapore, Oct. 28 -- US-based Gilead Sciences, Inc. has entered into a definitive agreement to acquire an oral IL-23R inhibitor programme, including lead asset HCXT-2001, from Hong Kong-based PepStar... Read More


CELSET launches Korean Botulinum Toxin Type A brand for International Markets

Singapore, Oct. 28 -- CELSET INC., a Korean biotechnology company specialising in medical aesthetics, has launched SOLTOX, its botulinum toxin type A brand, introducing a Korean botulinum toxin brand ... Read More


National Dental Centre Singapore inks MoU with HKU to advance collaboration in oral health research

Singapore, Oct. 28 -- The Singapore Population Oral Health Symposium was recently organised by the National Dental Centre Singapore (NDCS), that saw a gathering of thought leaders, healthcare professi... Read More


Japan's Otsuka BioVentures begins strategic equity investments

Singapore, Oct. 28 -- Japan-based Otsuka Pharmaceutical has announced that Otsuka BioVentures, LLC (OBV), a corporate venture capital (CVC) firm has begun strategic equity investments. OBV will make ... Read More


Abu Dhabi and Novartis activate Clinical Trials Hub through global Phase 3 programmes

Singapore, Oct. 28 -- The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, and Novartis have announced the initiation of the Abu Dhabi Clinical Trials Hub... Read More


Korea's Ardens Lifescience wins MedTech Innovator Asia Pacific 2026 Grand Prize

Singapore, Oct. 27 -- MedTech Innovator (MTI), the world's largest accelerator of medical device, digital health, and diagnostic companies, has announced Ardens Lifescience as the 2026 MedTech Innovat... Read More


Abu Dhabi government partners with Merck to advance fertility education, research and innovation

Singapore, Oct. 27 -- The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, has signed a Memorandum of Understanding (MoU) with Merck, a leading science an... Read More